<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">transmed</journal-id><journal-title-group><journal-title xml:lang="ru">Трансляционная медицина</journal-title><trans-title-group xml:lang="en"><trans-title>Translational Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2311-4495</issn><issn pub-type="epub">2410-5155</issn><publisher><publisher-name>Almazov National Medical Research Centre, Saint Petersburg, Russia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2311-4495-2018-5-5-5-11</article-id><article-id custom-type="elpub" pub-id-type="custom">transmed-439</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СЕРДЕЧНО-СОСУДИСТЫЕ ЗАБОЛЕВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CARDIOVASCULAR MEDICINE</subject></subj-group></article-categories><title-group><article-title>ПЕРИОДИЧЕСКАЯ ПНЕВМАТИЧЕСКАЯ КОМПРЕССИЯ В ЛЕЧЕНИИ ХРОНИЧЕСКИХ ОБЛИТЕРИРУЮЩИХ ЗАБОЛЕВАНИЙ АРТЕРИЙ НИЖНИХ КОНЕЧНОСТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>INTERMITTENT PNEUMATIC COMPRESSION FOR TREATING PERIPHERAL ARTERIAL DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6897-6171</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крутиков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Krutikov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., в.н.с. научно-исследовательского отдела инфильтративных заболеваний сердца</p></bio><bio xml:lang="en"><p>PhD, leading researcher of the research Department of infiltrative heart disease</p></bio><email xlink:type="simple">ankrutikov@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вавилов</surname><given-names>В. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Vavilov</surname><given-names>V. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор кафедры факультетской хирургии</p></bio><bio xml:lang="en"><p>MD, PhD, professor of the Department of faculty surgery</p></bio><email xlink:type="simple">vnvavilov@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Королев</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Korolev</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.т.н., зав. научно-исследовательским отделом нанотехнологий</p></bio><bio xml:lang="en"><p>PhD, head of the research Department of nanotechnology</p></bio><email xlink:type="simple">office@cardioprotect.spb.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семернин</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Semernin</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., зав. научно-исследовательским отделом инфильтративных заболеваний сердца</p></bio><bio xml:lang="en"><p>PhD, head of the research Department of infiltrative heart disease</p></bio><email xlink:type="simple">semernin@almazovcentre.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Костарева</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kostareva</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., директор Института молекулярной биологии и генетики</p></bio><bio xml:lang="en"><p>PhD, director of the Institute of Molecular Biology and Genetics</p></bio><email xlink:type="simple">akostareva@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Федеральное государственное бюджетное учреждение&#13;
«Национальный медицинский исследовательский центр&#13;
имени В. А. Алмазова» Министерства здравоохранения Российской&#13;
Федерации, Санкт-Петербург</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre, Saint Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский медицинский государственный университет им. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First Saint Petersburg State Medical University, Saint Petersburg</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2018</year></pub-date><volume>5</volume><issue>5</issue><fpage>5</fpage><lpage>11</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Крутиков А.Н., Вавилов В.Н., Королев Д.В., Семернин Е.Н., Костарева А.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Крутиков А.Н., Вавилов В.Н., Королев Д.В., Семернин Е.Н., Костарева А.А.</copyright-holder><copyright-holder xml:lang="en">Krutikov A.N., Vavilov V.N., Korolev D.V., Semernin E.N., Kostareva A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://transmed.almazovcentre.ru/jour/article/view/439">https://transmed.almazovcentre.ru/jour/article/view/439</self-uri><abstract><p>В обзоре отражены данные исследований по оценке эффективности</p><p>использования метода периодической пневматической компрессии для лечения хронических облитерирующих заболеваний артерий нижних конечностей. Рассмотрены основные режимы, обсуждаются возможные патофизиологические механизмы действия метода.</p></abstract><trans-abstract xml:lang="en"><p>The review discussed issues of intermittent pneumatic compression using for peripheral arterial disease treatment. Historical information, regimes and possible mechanisms of action are discussed.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>периодическая пневматическая компрессия</kwd><kwd>хронические облитерирующие заболевания артерии нижних конечностей</kwd></kwd-group><kwd-group xml:lang="en"><kwd>intermittent pneumatic compression</kwd><kwd>peripheral arterial disease (chronic obliliterative arterial disease)</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Schwahn-Schreiber C, Breu FX, Rabe E et al. S1-Leitlinie Intermittierende Pneumatische Kompression. Der Hautarzt. 2018;69(8):662–673.</mixed-citation><mixed-citation xml:lang="en">Schwahn-Schreiber C, Breu FX, Rabe E et al. S1-Leitlinie Intermittierende Pneumatische Kompression. Der Hautarzt. 2018; 69 (8): 662–673</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Junod VT. Traite theorique et pratique de l’hemospasie. Paris, A L’Imprimerie Nationale, 1875.</mixed-citation><mixed-citation xml:lang="en">Junod VT. Traite theorique et pratique de l’hemospasie. Paris, A</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bier A. Hyperämie als Heilmittel. Vogel, Leipzig, 1906.</mixed-citation><mixed-citation xml:lang="en">L’Imprimerie Nationale, 1875</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis T. The Force Exerted by the Minute Vessels of the Skin in Contracting. Heart. 1924;11:109-117.</mixed-citation><mixed-citation xml:lang="en">Bier A. Hyperämie als Heilmittel. Vogel, Leipzig, 1906</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lewis T., Grant R.T. Observations upon reactive hyperemia in man. Heart 1925; 12:73.</mixed-citation><mixed-citation xml:lang="en">Lewis T. The Force Exerted by the Minute Vessels of the Skin in</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Collens WS, Wilensky ND. The treatment of peripheral obliterative diseases by intermittent venous occlusion. JAMA. 1936;107:1960-1965.</mixed-citation><mixed-citation xml:lang="en">Contracting. Heart. 1924; 11:109</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kakkos SK, Geroulakos G, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superﬁcial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomized controlled trial. Eur J Vasc Endovasc Surg. 2005;30:164-75.</mixed-citation><mixed-citation xml:lang="en">Lewis T., Grant R.T. Observations upon reactive hyperemia in man. Heart 1925; 12:73</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Delis KT, Nicolaides AN, Wolfe JH et al. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg. 2000;31:650-61.</mixed-citation><mixed-citation xml:lang="en">Collens WS, Wilensky ND. The treatment of peripheral obliterative diseases by intermittent venous occlusion. JAMA. 1936; 107:1960-1965.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled study with 1-year follow-up. Ann Surg. 2005;241:431-41.</mixed-citation><mixed-citation xml:lang="en">Kakkos SK, Geroulakos G, Nicolaides AN. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomized controlled trial. Eur J Vasc Endovasc Surg. 2005; 30:164-75.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Berni A, Tromba L, Falvo L et al. Randomized study on the effects of different strategies of intermittent pneumatic compression for lower limb claudication. G Chir. 2009;30(6-7):269-73.</mixed-citation><mixed-citation xml:lang="en">Delis KT, Nicolaides AN, Wolfe JH, Stansby G. Improving walking ability and ankle brachial pressure indices in symptomatic peripheral vascular disease with intermittent pneumatic foot compression: a prospective controlled study with one-year follow-up. J Vasc Surg. 2000;31:650-61.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ramaswami G, D’Ayala M, Hollier LH et al. Rapid foot and calf compression increases walking distance in patients with intermittent claudication: results of a randomized study. J Vasc Surg. 2005;41(5):794-801.</mixed-citation><mixed-citation xml:lang="en">Delis KT, Nicolaides AN. Effect of intermittent pneumatic compression of foot and calf on walking distance, hemodynamics, and quality of life in patients with arterial claudication: a prospective randomized controlled</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">de Haro J, Acin F, Florez A et al. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. J Vasc Surg. 2010;51(4):857-62.</mixed-citation><mixed-citation xml:lang="en">study with 1-year follow-up. Ann Surg. 2005;241:431-41.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chang ST, Hsu JT, Chu CM et al. Using intermittent pneumatic compression therapy to improve quality of life for symptomatic patients with infrapopliteal diffuse peripheral obstructive disease. Circ J. 2012;76(4):971-6.</mixed-citation><mixed-citation xml:lang="en">Berni A, Tromba L, Falvo L. et al. Randomized study on the effects of different strategies of intermittent pneumatic compression for lower limb claudication. G Chir. 2009;30:269-73.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Breu FX, Zelikovski A, Loberman Z et al. Efﬁcacy and safety of a new pneumatic compression device for peripheral arterial disease with intermittent claudication: a prospective, randomized, multi-center clinical trial. Phlebologie. 2014;43(1):5-11.</mixed-citation><mixed-citation xml:lang="en">Ramaswami G, D’Ayala M, Hollier LH et al. Rapid foot and calf</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Sultan S, Hamada N, Soylu E et al. Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease. J Vasc Surg. 2011;54 (2):440-6.</mixed-citation><mixed-citation xml:lang="en">compression increases walking distance in patients with intermittent claudication: results of a randomized study. J Vasc Surg. 2005; 41:794-801.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Montori VM, Kavros SJ, Walsh EE et al. Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000). Int Angiol. 2002;21(4):360-6.</mixed-citation><mixed-citation xml:lang="en">de Haro J, Acin F, Florez A, Bleda S, Fernandez JL. A prospective randomized controlled study with intermittent mechanical compression of the calf in patients with claudication. J Vasc Surg. 2010; 51:857-62.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kavros SJ, Delis KT, Turner NS et al. Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-month follow-up. J Vasc Surg. 2008;47(3):543–9.</mixed-citation><mixed-citation xml:lang="en">Chang ST, Hsu JT, Chu CM et al. Using intermittent pneumatic compression therapy to improve quality of life for symptomatic patients with infrapopliteal diffuse peripheral obstructive disease. Circ J. 2012; 76:971-6.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Sultan S, Esan O, Fahy A. Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular. 2008;16(3):130-9.</mixed-citation><mixed-citation xml:lang="en">Breu FX, Zelikovski A, Loberman Z et al. Efficacy and safety of a new pneumatic compression device for peripheral arterial disease with intermittent claudication: a prospective, randomized, multi-center clinical trial. Phlebologie. 2014;43:5-11.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">van Bemmelen PS, Gitlitz DB, Faruqi RM et al. Limb salvage using high-pressure intermittent compression arterial assist device in cases unsuitable for surgical revascularization. Arch Surg. 2001;136(11):1280-5.</mixed-citation><mixed-citation xml:lang="en">Sultan S, Hamada N, Soylu E, et al. Sequential compression biomechanical device in patients with critical limb ischemia and nonreconstructible peripheral vascular disease. Vasc Surg. 2011; 54 (2):440–446.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Oresanya L, Mazzei M, Bashir R et al. Systematic review and meta-analysis of high-pressure intermittent limb compression for the treatment of intermittent claudication. J Vasc Surg. 2018;67(2):620-8.</mixed-citation><mixed-citation xml:lang="en">Montori VM et al. Intermittent compression pump for nonhealing wounds in patients with limb ischemia. The Mayo Clinic experience (1998-2000). Int Angiol. 2002; 21:360-366</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Williams KJ, Babber A, Ravikumar R et al. Non-Invasive Management of Peripheral Arterial Disease. Adv Exp Med Biol. 2017;906:387–406.</mixed-citation><mixed-citation xml:lang="en">Kavros SJ, Delis KT, Turner NS et al. () Improving limb salvage in critical ischemia with intermittent pneumatic compression: a controlled study with 18-monthfollow-up. J Vasc Surg. 2008; 47 (3):543–549.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Pawlaczyk K, Gabriel M, Urbanek T et al. Effects of intermittent pneumatic compression on reduction of postoperative lower extremity edema and normalization of foot microcirculation ﬂow in patients undergoing arterial revascularization. Med Sci Monit. 2015;21:3986-92.</mixed-citation><mixed-citation xml:lang="en">Sultan S, Esan O, Fahy A (2008) Nonoperative active management of critical limb ischemia: initial experience using a sequential compression biomechanical device for limb salvage. Vascular 16(3):130–139</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Spreen MI, Martens JM, Hansen BE et al. Percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv. 2016;9(2):e002376.</mixed-citation><mixed-citation xml:lang="en">van Bemmelen PS, Gitlitz DB, Faruqi RM et al. Limb Salvage Using High-Pressure Intermittent Compression Arterial Assist Device in Cases Unsuitable for Surgical Revascularization. Arch Surg. 200;136:1280-1285.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Tawﬁck WA, Hamada N, Soylu E et al. Sequential compression biomechanical device versus primary amputation in patients with critical limb ischemia. Vasc Endovascular Surg. 2013;47(7):532-9.</mixed-citation><mixed-citation xml:lang="en">Oresanya L., Mazzei M., Bashir R. et al. Systematic review and meta-analysis of high-pressure intermittent limb compression for the treatment of intermittent claudication. J Vasc Surg 2018;67:620-8.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Sheldon RD, Roseguini BT, Laughlin MH et al. New insights into the physiologic basis for intermittent pneumatic limb compression as a therapeutic strategy for peripheral artery disease. J Vasc Surg. 2013;58(6):1688-96.</mixed-citation><mixed-citation xml:lang="en">Williams K.J., Babber A., Ravikumar R. et al. Non-Invasive Management of Peripheral Arterial Disease. Adv Exp Med Biol 2017; 906: 387–406.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Husmann M, Willenberg T, Keo HH et al. Integrity of venoarteriolar reﬂex determines level of microvascular skin ﬂow enhancement with intermittent pneumatic compression. J Vasc Surg. 2008;48(6):1509-13.</mixed-citation><mixed-citation xml:lang="en">Pawlaczyk K., Gabriel M., Urbanek T. et al. Effects of intermittent pneumatic compression on reduction of postoperative lower extremity edema and normalization of foot microcirculation flow in patient undergoing arterial revascularization. Med Sci Monit. 2015; 21: 3986-3992.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Chen LE, Liu K, Qi WN et al. Role of nitric oxide in vasodilation in upstream muscle during intermittent pneumatic compression. J Appl Physiol. (1985). 2002;92(2):559-66.</mixed-citation><mixed-citation xml:lang="en">Spreen MI, Martens JM, Hansen BE et al. Percutaneous transluminal angioplasty and drug-eluting stens for infrapopliteal lesions in critical limb ischemia (PADI) trial. Circ Cardiovasc Interv. 2016; 9(2): e002376.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Dai G, Tsukurov O, Orkin RW et al. An in vitro cell culture system to study the inﬂuence of external pneumatic compression on endothelial function. J Vasc Surg. 2000;32(5):977-87.</mixed-citation><mixed-citation xml:lang="en">Tawfick WA, Hamada N, Soylu E et al. Sequential compression</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kohro S, Yamakage M, Sato K et al. Intermittent pneumatic foot compression can activate blood ﬁbrinolysis without changes in blood coagulability and platelet activation. Acta Anaesthesiol Scand. 2005;49(5):660-4.</mixed-citation><mixed-citation xml:lang="en">biomechanical device versus primary amputation in patients with critical limb ischemia. Vasc Endovascular Surg 2013; 47(7):532–539.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Giddings JC, Morris RJ, Ralis HM et al. Systemic haemostasis after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol. 2004;26(4):269-73.</mixed-citation><mixed-citation xml:lang="en">Sheldon RD, Bruno T, Laughlin MH. New insights into the physiologic basis for intermittent pneumatic limb compression as a therapeutic strategy for peripheral artery disease. J Vasc Surg. 2013; 58:1688-1696.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost. 2010;103(4):696-709.</mixed-citation><mixed-citation xml:lang="en">Husmann M, Willenberg T, Keo HH et al. Integrity of venoarteriolar reflex determines level ofmicrovascular skin flow enhancement with intermittent pneumatic compression. J Vasc Surg 2008; 48(6):1509–1513.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Morris RJ, Woodcock JP. Intermittent venous compression, and the duration of hyperaemia in the common femoral artery. Clin Physiol Funct Imaging. 2004; 24(4):237-42.</mixed-citation><mixed-citation xml:lang="en">Chen LE, Liu K, Qi WN, Joneschild E et al. Role of nitric oxide in</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">vasodilation in upstream muscle during intermittent pneumaticcompression. J Appl Physiol (1985). 2002;92(2):559-566.</mixed-citation><mixed-citation xml:lang="en">vasodilation in upstream muscle during intermittent pneumaticcompression. J Appl Physiol (1985). 2002;92(2):559-566.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Dai G, Tsukurov O, Orkin RW et al. An in vitro cell culture system to study the influence of external pneumatic compressionon endothelial function. J Vasc Surg. 2000; 32(5):977-87.</mixed-citation><mixed-citation xml:lang="en">Dai G, Tsukurov O, Orkin RW et al. An in vitro cell culture system to study the influence of external pneumatic compressionon endothelial function. J Vasc Surg. 2000; 32(5):977-87.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Kohro S, Yamakage M, Sato K et al. Intermittent pneumatic foot compression can blood fibrinolysis without changes in blood coagulability and platelet activation. Acta Anaesthesiol Scand. 2005 May;49(5):660-4.</mixed-citation><mixed-citation xml:lang="en">Kohro S, Yamakage M, Sato K et al. Intermittent pneumatic foot compression can blood fibrinolysis without changes in blood coagulability and platelet activation. Acta Anaesthesiol Scand. 2005 May;49(5):660-4.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Giddings JC, Morris RJ, Ralis HM, et al. Systemic haemostasis</mixed-citation><mixed-citation xml:lang="en">Giddings JC, Morris RJ, Ralis HM, et al. Systemic haemostasis</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol. 2004; 26(4):269-73.</mixed-citation><mixed-citation xml:lang="en">after intermittent pneumatic compression. Clues for the investigation of DVT prophylaxis and travellers thrombosis. Clin Lab Haematol. 2004; 26(4):269-73.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery Haemost. 2010;103(4):696-709.</mixed-citation><mixed-citation xml:lang="en">Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery Haemost. 2010;103(4):696-709.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Morris RJ, Woodcock JP. Intermittent venous compression, and the duration of hyperaemia in the common femoral artery. Clin Physiol Funct Imaging. 2004; 24:237–242.</mixed-citation><mixed-citation xml:lang="en">Morris RJ, Woodcock JP. Intermittent venous compression, and the duration of hyperaemia in the common femoral artery. Clin Physiol Funct Imaging. 2004; 24:237–242.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
